Evidence map›Paper›PMID 35387335›Full record

ArticleFrontiers in pharmacology2022

Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis.

Kam Wa Chan, Kam Yan Yu, Wai Han Yiu, Rui Xue, Sarah Wing-Yan Lok, Hongyu Li, Yixin Zou, Jinyuan Ma, Kar Neng Lai, Sydney Chi-Wai Tang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Potential Antidiabetic Activity of β-sitosterol fromCombinatorial chemistry & high throughput screening · 2024
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kam Wa ChanDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Kam Yan YuDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Wai Han YiuDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Rui XueDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Sarah Wing-Yan LokDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Hongyu LiDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Yixin ZouDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Jinyuan MaDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Kar Neng LaiDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Sydney Chi-Wai TangDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, China.
University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic kidney diseasediabetic nephropathyintegrative medicinemechanismnetwork pharmacologyRehmanniaTNFtraditional Chinese medicine

Identifiers

PMID35387335
PMCPMC8977554
OpenAlexW4225755283

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.